Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies
Author:
Funder
Russian Science Foundation
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Bioengineering
Link
https://link.springer.com/content/pdf/10.1007/s12668-022-00991-1.pdf
Reference298 articles.
1. Althuis, M. D., Dozier, J. M., Anderson, W. F., Devesa, S. S., & Brinton, L. A. (2005). Global trends in breast cancer incidence and mortality 1973-1997. International Journal of Epidemiology, 34, 405–412. https://doi.org/10.1093/ije/dyh414
2. DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A., et al. (2019). Breast cancer statistics, 2019. CA: a Cancer Journal for Clinicians, 69, 438–451. https://doi.org/10.3322/caac.21583
3. DeSantis, C. E., Bray, F., Ferlay, J., Lortet-Tieulent, J., Anderson, B. O., & Jemal, A. (2015). International variation in female breast cancer incidence and mortality rates. Cancer Epidemiology, Biomarkers & Prevention, 24, 1495–1506. https://doi.org/10.1158/1055-9965.EPI-15-0535
4. American Cancer Society (2018) Global Cancer - Facts&Figures 4th Edition. Am Cancer Soc :12–5.
5. Morris, G. J., Naidu, S., Topham, A. K., Guiles, F., Xu, Y., McCue, P., et al. (2007). Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: A single-institution compilation compared with the national cancer institute’s surveillance, epidemiology, and end results database. Cancer, 110, 876–884. https://doi.org/10.1002/cncr.22836
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer;Journal of Controlled Release;2024-02
2. Phenanthroindolizidine Alkaloids Isolated from Tylophora ovata as Potent Inhibitors of Inflammation, Spheroid Growth, and Invasion of Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2022-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3